(Q36853419)

16 August 2017

title

Antibody humanization using monovalent phage display (English)

1 reference

16 August 2017

0 references

1 reference

Baca M

1

1 reference

16 August 2017

Presta LG

series ordinal

2

1 reference

16 August 2017

O'Connor SJ

series ordinal

3

1 reference

16 August 2017

Wells JA

series ordinal

4

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 April 1997

1 reference

Journal of Biological Chemistry

16 August 2017

published in

1 reference

16 August 2017

volume

272

1 reference

16 August 2017

issue

16

1 reference

16 August 2017

page(s)

10678-10684

1 reference

Reshaping human antibodies for therapy

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.16.10678

Replacing the complementarity-determining regions in a human antibody with those from a mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.16.10678

A humanized antibody that binds to the interleukin 2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.16.10678

Humanization of a mouse monoclonal antibody by CDR–grafting: the importance of framework residues on loop conformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.16.10678

Reshaping a human monoclonal antibody to inhibit human respiratory syncytial virus infection in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.16.10678

Humanization of an anti-p185HER2 antibody for human cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.16.10678

X-ray structures of fragments from binding and nonbinding versions of a humanized anti-CD18 antibody: structural indications of the key role of VH residues 59 to 65

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.16.10678

Conformations of immunoglobulin hypervariable regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.16.10678

Structure, function and properties of antibody binding sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.16.10678

Humanization of murine monoclonal antibodies through variable domain resurfacing

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.16.10678

Human-engineered monoclonal antibodies retain full specific binding activity by preserving non-CDR complementarity-modulating residues

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.16.10678

Development of humanized bispecific antibodies reactive with cytotoxic lymphocytes and tumor cells overexpressing the HER2 protooncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.16.10678

Hormone phage: an enrichment method for variant proteins with altered binding properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.16.10678

Selecting high-affinity binding proteins by monovalent phage display

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.16.10678

The vascular endothelial growth factor proteins: identification of biologically relevant regions by neutralizing monoclonal antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.16.10678

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.16.10678

Fab assembly and enrichment in a monovalent phage display system

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.16.10678

High-level secretion of human growth hormone by Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.16.10678

Production of single-stranded plasmid DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.16.10678

DNA sequencing with chain-terminating inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.16.10678

Framework residue 71 is a major determinant of the position and conformation of the second hypervariable region in the VH domains of immunoglobulins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.16.10678

Making antibodies by phage display technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.16.10678

A combinatorial library strategy for the rapid humanization of anticarcinoma BR96 Fab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.16.10678

Kinetic analysis of monoclonal antibody-antigen interactions with a new biosensor based analytical system

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.16.10678

Monoclonal antibody therapy. Anti-idiotypic and non-anti-idiotypic antibodies to OKT3 arising despite intense immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.16.10678

Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.16.10678

Canonical structures for the hypervariable regions of immunoglobulins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.16.10678

Antibody framework residues affecting the conformation of the hypervariable loops

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.16.10678

A possible procedure for reducing the immunogenicity of antibody variable domains while preserving their ligand-binding properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.16.10678

21 January 2018

Identifiers

DOI

10.1074/JBC.272.16.10678

1 reference

16 August 2017

1 reference